-- Products will be available in early Summer 2018 at in-store and
online retailers nationwide

April 24, 2018 07:00 AM Eastern Daylight Time

LOS ANGELES--(EON: Enhanced Online News)--Level Brands Inc. (NYSE American: LEVB), an innovative marketing and
licensing company that provides bold, unconventional, and socially
responsible branding for leading businesses, and Vancouver-based Isodiol
International Inc. (CSE: ISOL, OTCQB: ISOLF), a global bioactive
phytoceutical innovator, specializing in the development of
pharmaceutical and wellness products, announced today the launch of
their newest jointly developed cannabidiol (CBD) products. The products
are CBD pain-relieving cream, marketed under LEVB subsidiary Ireland Men
One (I’M1); CBD oral sprays marketed under BeTrū | kathy ireland®
Health & Wellness; and CBD edibles, marketed under Chef Andre Carthen
Edibles. The new products will be available in early Summer 2018 at
in-store and online retailers nationwide. According to The Hemp
Business Journal (as reported by forbes.com), the CBD market will
grow to $2.1 billion by 2020.

In January 2018, Level Brands and Isodiol signed a license agreement, to
work together to develop consumer products for kathy ireland® Health &
Wellness, a licensor to Level Brands; products under the Chef Andre
Carthen and Nicholas Walker brands, also licensors to Level Brands; as
well as products for Level Brands subsidiary I’M1, the company’s
lifestyle brand for millennial men. The license agreement is valued at
$32 million.

“Our collaboration with Level Brands is taking a big step forward
today,” said Marcos Agramont, CEO of Isodiol. “When we established this
partnership, we envisioned bringing a variety of consistent, highly
bioactive CBD products to the market and today is just the early stages
of this process. Through Kathy’s large network and consumer base, not
only are we able to target a variety of new mainstream channels, but we
are also able to further achieve our goal of helping people around the
globe understand how CBD is beneficial for the human body.”

“When we announced the extension of our license agreement with Isodiol
this past January, we said that our vision is that Isodiol will become
the leading CBD company in the world,” says Kathy Ireland, Level Brands’
Chairman Emeritus and Chief Brand Strategist. “The products we’re
launching, take us in that direction in a powerful way. We continue to
believe, based on our exhaustive research and decades of brand building,
that the CBD industry will see enormous growth over the next decade on a
global scale. Hemp has many natural and important uses that are
beneficial in countless ways. It is important for people to remember
that hemp, without THC, is similar to a grape without fermentation. It
has no undesired psychological side effects. The Level
Brands and Isodiol collaboration is bringing, and will continue to bring
to market, the best quality hemp-derived CBD products, without any
psychotropic elements.”

Martin Sumichrast, Chairman and CEO of Level Brands, said, “Level Brands
and Isodiol have embarked on a decade-long partnership which has the
potential to not only sell a significant amount of consumer-branded
products worldwide but also bring to market new, innovative means that I
believe will provide consumers the best benefits of CBD. The products
we’re launching represent the cutting edge of innovation and a new way
of thinking about CBD.”

“CBD is here, it’s happening, and it’s only going to be bigger,” said
Tommy Meharey, Marine, millennial father, lifestyle leader, and the
youngest board member of kathy ireland® Worldwide - who co-founded I’M1
with Kathy Ireland. “Steadily, minds are changing as people are becoming
more educated and informed about what CBD is and how it is different
than THC-based products. CBD is an amazing compound and I’m overjoyed
that we are part of this great and fast-growing movement.”

“We’re thrilled at the debut of CBD edibles,” said celebrity Chef Andre
Carthen, also known as the Fit Chef. Chef Andre has contributed to a New
York Times #1 best seller and has appeared on numerous network
television shows, and national magazines and newspapers. “In CBD
edibles, the CBD is released slowly as the food is digested, and
therefore they provide those taking them with longer lasting relief.”

Stephen Roseberry and Jon Carrasco serve as President & CMO, and Global
Creative Director, respectively, for kathy ireland® Worldwide and
all of its Level Brands licensing entities, including I’M1,

kathy ireland® Health & Wellness, and EE1, the brand management
subsidiary, co-founded by Nic Mendoza. All CBD products are THC-free and
non-psychoactive while focusing on the natural, positive effects CBD has
on our bodies. All products use hemp-derived, 99%+ pure, bioactive, and
pharmaceutical-grade CBD. The products promote a holistic and natural
lifestyle and are made in the USA.

Level Brands creates bold, unconventional, and socially responsible
branding for leading businesses. Level Brands specializes in corporate
brand management and consumer products marketing art, beauty, fashion,
health and wellness, and entertainment. Licensed brand marketing is at
the core of the Level Brands businesses, among which are Ireland Men One
or I’M1, for millennial men and the women who love them; Encore Endeavor
One or EE1, corporate brand management and producer of experiential
entertainment events and products across multiple platforms; kathy
ireland® Health & Wellness; and Beauty & Pin-Ups, Level Brands’
hair-care and disruptive women’s-products brand.

Isodiol International, Inc. is the market leader in pharmaceutical grade
phytochemical compounds and the industry leader in the manufacturing and
development of phytoceutical consumer products. Isodiol is the pioneer
of many firsts for the cannabis industry including commercialization of
99%+ pure, bioactive pharmaceutical grade cannabinoids,
micro-encapsulations, and nanotechnology for the highest quality
consumable and topical skin care products. Isodiol’s growth strategy
includes the development of over-the-counter and pharmaceutical drugs,
expanding its phytoceutical portfolio, and aggressively continuing its
international expansion into Latin America, Asia, and Europe.

Forward-looking Statements

This press release contains certain forward-looking statements that are
based on current expectations and involve certain risks and
uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can be
identified by the use of words such as “should,” “may,” “intends,”
“anticipates,” “believes,” “estimates,” “projects,” “forecasts,”
“expects,” “plans,” and “proposes.” These forward-looking statements are
not guarantees of future performance and are subject to risks,
uncertainties, and other factors, some of which are beyond our control
and difficult to predict and could cause actual results to differ
materially from those expressed or forecasted in the forward-looking
statements. You are urged to carefully review and consider any
cautionary statements and other disclosures, including the statements
made under the heading “Risk Factors” in Level Brands Inc.’s Annual
Report on Form 10-K for the fiscal year ended September 30, 2017 as
filed with the Securities and Exchange Commission (the “SEC”) on
December 26, 2017 and our other filings with the SEC. Level Brands Inc.
does not undertake any duty to update any forward-looking statements
except as may be required by law.